ReActiv8 Post Market Surveillance Registry
- Conditions
- Chronic Low Back Pain
- Registration Number
- NCT03255200
- Lead Sponsor
- Mainstay Medical
- Brief Summary
To gather data on the long-term safety of ReActiv8 and identify any residual risks by reporting all Serious Adverse Device Effects as well as performance and health care utilization through two years post-implant.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 87
- Meet the Indications for ReActiv8
- Willing to sign the Informed Consent for the Registry
- Age ≥ 18 years
- Subjects will be excluded from the Registry if they are contraindicated for ReActiv8.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Low Back Pain - Numeric Pain Rating (NRS) Scale 90 days, 180 days, 1 year, 2 years post Activation Change in low back pain Numerical Rating Scale (NRS) compared to Baseline. The NRS is an 11-point scale where 0 means no pain at all and 10 means worst imaginable pain. Patients were asked to rate their average low back pain in the last 24 hours. Lower scores or reduction in score means an improvement or reduction in pain.
- Secondary Outcome Measures
Name Time Method Serious Adverse Device Effects Through 2 years post Activation All serious device- or procedure-related adverse events.
Trial Locations
- Locations (5)
Katholisches Klinikum Koblenz
🇩🇪Koblenz, Germany
Orthopadisches Krankenhaus Schloss Werneck
🇩🇪Werneck, Balthasar-Neumann, Germany
Klinikum Magdeburg
🇩🇪Magdeburg, Germany
Medizinisches Versorgungszentrum Steinburg gGmbH
🇩🇪Itzehoe, Germany
BG Klinikum Bergmannstrost
🇩🇪Halle, Germany